Apobec3 Mouse shRNA Plasmid (Locus ID 80287)
CAT#: TR505334
Apobec3 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Apobec3 Mouse shRNA Plasmid (Locus ID 80287) |
Locus ID | 80287 |
UniProt ID | Q99J72 |
Synonyms | Apobec; Arp3; BC003314; Cem15; Rfv3 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | Apobec3 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 80287). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC003314, NM_001160415, NM_001347041, NM_030255, NM_030255.1, NM_030255.2, NM_030255.3, NM_001160415.1, BC007182 |
Summary | DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. Exhibits antiviral activity against HIV-1, simian immunodeficiency viruses (SIVs), mouse mammary tumor virus (MMTV) and friend murine leukemia virus (FrMLV) and may inhibit the mobility of LTR retrotransposons.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
,null,
Nature Communications
,PubMed ID 33772027
[Apobec3]
|
APOBEC3 mediates resistance to oncolytic viral therapy
,Huff, A;Wongthida, P;Kottke, T;Thompson, J;Driscoll, C;Schuelke, M;Shim, K;Harris, R;Molan, A;Pulido, J;Selby, P;Harrington, K;Melcher, A;Evgin, L;Vile, R;,
Molecular Therapy - Oncolytics
,PubMed ID 30294666
[APOBEC3]
|
Documents
Product Manuals |
FAQs |
SDS |
其它Apobec3产品
Customer
Reviews
Loading...